Erythromycin Estolate USP API Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Erythromycin Estolate USP API

Product Overview

Erythromycin Estolate USP is a macrolide antibiotic active pharmaceutical ingredient (API). Chemically, it is the dodecyl sulfate salt of erythromycin 2′-propionate. The estolate form combines an erythromycin propionate derivative with a dodecyl sulfate counterion. It is supplied for pharmaceutical manufacturing and formulation development in accordance with the applicable approved material specification.

Erythromycin Estolate is a distinct chemical form and should not be treated as interchangeable by identity or specification with erythromycin base, erythromycin stearate or erythromycin ethylsuccinate.

Chemical Identification

  • Product name: Erythromycin Estolate
  • Pharmacopoeial reference: USP
  • CAS number: 3521-62-8
  • Molecular formula: C₅₂H₉₇NO₁₈S
  • Molecular weight: 1056.39 g/mol
  • Chemical description: Erythromycin 2′-propionate dodecyl sulfate (salt)

The formula and molecular weight refer to the complete estolate salt, rather than erythromycin base alone. <Cite refs={["turn157024search0","turn157024search4"]}/>

Mechanism of Action

Erythromycin acts by binding reversibly to the 50S subunit of susceptible bacterial ribosomes. This interferes with bacterial protein synthesis, including peptide-chain elongation and translocation. Its action is generally bacteriostatic, although the observed effect can depend on concentration and organism susceptibility. <Cite refs={["turn157024search4"]}/>

Physical and Chemical Characteristics

Erythromycin Estolate is commonly described in commercial chemical specifications as a white crystalline powder. It is practically insoluble in water. Appearance and solubility should be confirmed against the current batch certificate of analysis (COA) and the applicable USP test requirements. <Cite refs={["turn157024search19"]}/>

USP Potency Requirement

The USP-NF monograph states that Erythromycin Estolate has a potency equivalent to not less than 600 µg of erythromycin (C₃₇H₆₇NO₁₃) per mg, calculated on the anhydrous basis. This is an erythromycin-equivalent potency requirement. It must not be represented as a generic HPLC assay limit of 98.0–102.0% for the complete salt. Use the current official USP monograph and validated method when setting release criteria. <Cite refs={["turn157024search0"]}/>

Applications

Erythromycin Estolate is used as an antibacterial pharmaceutical ingredient in the manufacture of suitable erythromycin-containing formulations. Its use in a finished dosage form requires formulation-specific compatibility, stability, quality and regulatory assessment. This product page is intended for pharmaceutical ingredient procurement and manufacturing information, not patient treatment guidance.

Quality Control and Compliance

Quality evaluation should be performed against the current USP monograph, the approved manufacturer specification and the batch-specific COA. Relevant controls may include identification, erythromycin-equivalent potency, water content, related substances, residual solvents where applicable, and microbiological quality where required by the intended use. Do not infer a test limit or analytical method from a supplier catalogue specification.

Packaging and Storage

Package in a well-closed, appropriately protective container suitable for the material and its validated stability profile. Protect from moisture, excessive heat and contamination. The actual storage temperature, retest period and transport conditions must follow the approved product specification and stability data.

Safety and Handling

Handle as a pharmaceutical antibiotic raw material using suitable industrial hygiene practices. Avoid generating or inhaling dust and prevent unnecessary skin and eye contact. Use appropriate personal protective equipment and follow the current safety data sheet (SDS), site procedures and applicable environmental requirements.

Frequently Asked Questions

What is Erythromycin Estolate?
It is the dodecyl sulfate salt of erythromycin 2′-propionate, a distinct macrolide antibiotic form.

What is its CAS number?
The commonly referenced CAS number is 3521-62-8.

What is the USP potency requirement?
The USP monograph specifies a potency equivalent to NLT 600 µg of erythromycin per mg, calculated on the anhydrous basis.

Is the USP potency requirement the same as an HPLC assay percentage?
No. It is expressed as erythromycin-equivalent potency. The prescribed monograph method and calculation should be followed.

Is Erythromycin Estolate the same as Erythromycin Stearate?
No. They are different salts/derivatives and have separate identity and quality requirements.

Enquiry

For pharmaceutical manufacturing enquiries, request the current batch COA, applicable USP compliance documentation, analytical method details, packaging information and availability confirmation. Final acceptance should be based on the buyer’s approved specification and verification of the supplied batch documentation.

Detailed Specifications

Parameter Specification
Appearance White crystalline powder
Identification IR and HPLC complaint
Assay (HPLC) 97.0–103.0%
Loss on Drying NMT 0.5%
Residue on Ignition NMT 0.1%
Heavy Metals NMT 10 ppm
Solubility Practically insoluble in water
Get Bulk Quote via WhatsApp
chatbot/chatbot.js" defer>